BETA: Study in Prediabetes Type 2 Diabetes

This study is testing the feasibility of using non-invasive, remote digital tools including continuous glucose monitors (CGMs) and the Oura Ring to predict the function of beta-cells, the cells in the pancreas that secrete insulin. This study is being done in individuals with prediabetes or Type 2 diabetes. The aim is to develop remote digital tools that can predict the health and functioning of the pancreas in people with prediabetes or Type 2 diabetes, allowing personalized treatment approaches to preserve insulin secretion.

NCT Number	NCT07598773
Lead Sponsor	4YouandMe Collaborators: Buck Institute for Research on Aging, Phenome Health, AgileOps, Oregon State University
Conditions	Prediabetes, Type 2 Diabetes
Enrollment	130 participants
Start Date	2026-03-25
Primary Completion	2027-02-01 (estimated)
Study Completion	2027-02-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-20